KNCV Publications 2024

Nwokoye N, Ihesie A, Olabamiji J, Ochei K, Eneogu R, Odume B et al. Exploring the perspectives of healthcare workers and Program managers on the use of Truenat as a new tool for TB and DR-TB diagnosis in Nigeria: A qualitative study. PLoS One. December 30, 2024.
Pelzer PT, Stuck L, Martinez L, Richards AS, Acuña-Villaorduña C, Aronson NE, Bonnet M, Carvalho AC, Chan PC, et al. Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.The Lancet Microbe. December 19, 2024.
Jaganath D, Nabeta P, Nicol MP, Castro R, de Haas P, Tiemersma E, et al. Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study. CM. medRxiv December 18, 2024. (PRE-PRINT)
Goscé L, Tadesse AW, Foster N, van Kalmthout K, van Rest J, van der Wal J, Harker MJ, Madden N, Abdurhman T, Gadissa D, Bedru A, Dube TN, Alacapa J, Mganga A, Deyanova N, Charalambous S, Letta T, Jerene D, White R, Fielding KL, Houben RM, McQuaid CF. Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia. BMJ Glob Health. 9(12):e016997. December 9, 2024.
Ihesie A, Chukwuogo O, Eneogu R, Daniel OK, Agbaje A, Odume B et al. Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients’ and Healthcare Workers’ Perspectives. Trop Med. Infect Dis. December 7, 2024.
Odume B, Ogbudebe C, Mukadi Y, Dim C, Chukwu E, Chukwuogo O et al. The burden of subclinical TB in Nigeria. Public Health Action. December 1, 2024.
Shewamene Z, Belachew M, Shiferaw A, De Groot L, Sahlie M, Gadissa D et al., Facilitators and barriers to uptake of digital adherence technologies in improving TB care in Ethiopia: A qualitative study. PLOS Digit Health. November 21, 2024.
Wares DF, Mbenga M, Mirtskhulava V, Quelapio M, Slyzkyi A, Koppelaar I, Cho SN, Go U, Lee JS, Jung J-K, Everitt D, Foraida S, Diachencko M, Juneja S, Burham E, Totkogonova A, Myint Z, Flores I, Lytvynenko NA, Parpieva N, Nhung NV & Gebhard A. Introducing BPaL: Experiences from countries supported under the LIFT-TB project. PLoS ONE 19(11): e0310773. November 19, 2024.
Carratalà-Castro L, Munguambe S, Saavedra-Cervera B, de Haas P, Kay A, Marcy O, Nabeta P, Ssengooba W, Ghimenton-Walters E, Acácio S, Bonnet M, Ehrlich J, DiNardo AR, Vasiliu A, Lange C, Hermans S, Mandalakas AM, López-Varela E, García-Basteiro AL, on behalf of the Stool4TB Global Partnership. Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysis. Lancet Microbe 100963. November 11, 2024.
Pelzer PT, Holleman M, Helinski MEH, Weinberg AL, Buis J, Beattie P, Nyirenda T, van Rest J, Voss G. The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa. PLoS ONE 19(10): e0292981. October 28, 2024.
Sumner T, Clark RA, Prys-Jones TO, Bakker R, Churchyard G, White RG. The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa. AIDS. October 11, 2024.
Hermans N, de Zwaan R, Mulder A, van den Dool J, van Soolingen D, Kremer K, Anthony R. Mycobacterium tuberculosis complex sample processing by mechanical lysis, an essential step for reliable whole genome sequencing. Journal of Microbiological Methods, Volume 227,2024. October 10, 2024.
Spruijt I, Verhage A, Procee F, Vrubleuskaya N, Mulder C, Akkerman O. Perceptions and clinical practices associated with post-TB health and well-being in the Netherlands. IJTLD Open. 1(10):480-482. October 1, 2024.
Ihesie A, Nwokoye N, Olabamiji J, Ochei K, Eneogu R, Nongo D, Babayi A, Olugbemiga R, Odume B, Agbaje A, Oyelaran O, van Germert W, Mupfumi L, Amos O, Emeka E, Anyaike C, Ossai EN. Perceived ease of use of Truenat among laboratory staff as a new diagnostic tool for TB in Nigeria: Result of a pilot roll-out. PLOS Glob Public Health. 4(9):e0003652. September 20, 2024.
Salazar-Austin N, Bergman AJ, Mulder C, Tudor C, Mulatu F, Conradie G, Chaisson RE, Golub JE, Churchyard G, Bedru A and Kerrigan D. Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative research. BMC Health Serv Res 24, 1043. September 10, 2024
Eneogu R, Olabamiji J, Ihesie A, Nwokoye N, Ochei K, Nwadike P, Salau O, Munguno Z, Odume B, Agbaje A, Nongo D, Oyelaran O, van Germert W, Mupfumi L, Emeka E, Anyaike C, Ossai EN. Impact of Truenat on TB diagnosis in Nigeria. Public Health Action. 14(3):124-128. September 1, 2024.
Tesema E, Biru M, Leta T, Kumsa A, Liaulseged A, Gizatie G, Bogale T, Million M, Datiko DG, Gebreyohannes A, Molla Y, Hiruy N, Mbenga M, Suarez PG, Dememew ZG, Jerene D. Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends. PLoS ONE 19(8). August 26, 2024.
Buis JS, Jerene D, Gebhard, A, Bakker R, Majidulla A, Kerkhoff AD, Limaye RJ, Pelzer PT. Mapping the existing body of knowledge on new and repurposed TB vaccine implementation: A scoping review. PLOS Glob Public Health 4(8): e0002885, August 22, 2024.
Gonçalves Tasca B, Mganga A, Leung CL, Shilugu L, Pell C, Onjare B, Luvanda N, Mleoh L, de Groot L,van Kalmthout K, Fielding K, Jerene D. Factors related to the utilization of digital adherence technologies in tuberculosis care: A qualitative study among adults in DS-TB treatment, health care providers and other key actors in Tanzania. PLOS Glob Public Health. August 8, 2024.
Lienhardt C, Dooley KE, Nahid P, Wells C, Ryckman TS, Kendall EA, Davies G, Brigden G, Churchyard G, Cirillo DM, Di Meco E, Gopinath R, Mitnick C, Scott C, Amanullah F, Bansbach C, Boeree M, Campbell M, Conradie F, Crook A, Daley CL, Dheda K, Diacon A, Gebhard A, et al. Target regimen profiles for tuberculosis treatment. Bull World Health Org. 102(8):600-607. August 1, 2024.
Myrzaliev B, Ahmatov M, Duishekeeva A, Kulzhabaeva A, Kadyrov A, Toktogonova A, Abdulaeva G, Wares DF, Mirtskhulava V, Mbenga M, Slyzkyi A, Foraida S, Diachenko M, Juneja S, Turdumambetova G, Musaeva A, Gebhard A. Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan. J Clin Tuberc Other Mycobact Dis. 36:100472. July 26, 2024.
Leung CL, Alacapa J, Tasca BG, Villanueva AD, Masulit S, Ignacio ML, Uy KN, Pell C, van Kalmthout K, Powers R, Fielding K, Jerene D. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study. JMIR Hum Factors 2024;11:e54117, July 23, 2024.
Kobamo MM, Bekele FB, Simachew Y, Abebe MT, Abore KW. Self-care practice and associated factors among patients with diabetes on follow-up at Yirgalem General Hospital, Sidama, Ethiopia: a cross-sectional study. BMC Endocr Disord. July 11, 2024.
Gerste AK, Majidulla A, Baidya A, Pelzer PT, Jerene D, Buis JS et al. Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review. Expert Rev Vaccines 2024.
Tunje A, Persson HA, Jerene D, Hallstrom I. Intervention fidelity and factors affecting the process of implementing a mobile phone text messaging intervention among adolescents living with HIV: a convergent mixed-methods study in southern Ethiopia. BMJ Open. July 3, 2024.
Kohler S, Achar J, Mulder C, Sitali N, Paul N. Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024. Global Health 20, 51. June 25, 2024.
Macdonald SH, France NF, Hodgson I, Ali F, Dewi C, Runtu YM, Juan A, Sugiharto J, Byrne E, Conroy RM et al. Piloting “From the Inside Out” – a toolkit addressing tuberculosis-related self-stigma. BMC Glob Public Health. June 1, 2024.
Deribew AA, Dememew ZG, Alemu KM, Tefera G, Negash SG, Woldegiorgis AG et al. TB-related catastrophic costs in Ethiopia. Public Health Action. June 1, 2024.
Gordon I, Odume B, Ogbudebe C, Chukwuogo O, Nwokoye N, Useni S, Gidado M et al. Perception, acceptability and challenges of digital adherence technology among TB healthcare workers. Public Health Action. June 1, 2024.
Ogbudebe C, Odume B, Gordon I, Chukwuogo O, Nwokoye N, Gidado M et al. Appraising perception, accessibility and uptake of DAT among patients with TB. Public Health Action. June 1, 2024.
van der Westhuizen H, Nice JA, Tudor C, Liu Y, Ahmedov S, Kansal AR, Jensen PA, Vincent RL, Mustapha G, Vauhkonen V, Ochoa Delgado IM, van der Walt M, Volchenkov G. Embracing novel thinking to safeguard against airborne pathogens in indoor spaces. IJTLD Open;1(6):239-241. June 1, 2024.
Amofa-Sekyi M, Schaap A, Mureithi L, Kosloff B, Cheeba M, Kangololo B, de Haas P et al. Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting. PLOS Glob Public Health. May 20, 2024.
Gebreegziabher SB, Ashuro AA, Kumssa TH, Teferi MY, Alemayue EA, Shagre MB et al. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review. BMC Infect Dis. May 17, 2024.
Nwokoye N, Odume B, Nwadike P, Anaedobe I, Mangoro Z, Umoren M, Ogbudebe C, Chukwuogo O, Useni S, Nongo D, Eneogu R, Elom E, de Haas P, Gidado M. Impact of the Stool-Based Expert Test on Childhood Tuberculosis Diagnosis in Selected States in Nigeria. Trop. Med. Infect. Dis., May 1, 2024.
Hansen MA, Lekodeba NA, Chala L, Leong R, Keller S, Spruijt I et al. Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines). BMJ Open. April 17, 2024.
Schievano F, Mwamwitwa KW, Kisenge S, Mmari E, Duga A, Elagbaje C et al. Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries. Front Med. April 17, 2024.
Yenew B, de Haas P, Babo Y, Diriba G, Sherefdin B, Bedru A, Tegegn B, Gudina T, Getahun T, Abdella S, Jerene D, Klinkenberg E, Tiemersma E, Dememew ZG, Mengesha E, Sahile M, Zerihun B, Amare M, Tesfaye E, Meaza A, Slyzkyi A. Diagnostic accuracy, feasibility, and acceptability of stool-based testing for childhood tuberculosis. ERJ OPEN, April 11, 2024.
Mbenga M, Slyzkyi A, Mirtskhulava V, Pak S, Gebhard A, Utepkalieva G, Sagimbekova A, Adenov M, Ryskulov G. Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings. IJTLD OPEN, April 1, 2024, pp. 192-194(3)
Dixit K, Rai B, Aryal TP, de Siqueira-Filha NT, Levy JW, van Rest J et al. Stigma, depression, and quality of life among people with pulmonary tuberculosis diagnosed through active and passive case finding in Nepal: a prospective cohort study. BMC Glob Public Health. March 24, 2024.
Allwood B.W, Nightingale R, Agbota G, Auld S, Bisson G.P, Byrne A, Dunn R, Evans D, Hoddinott G, Gunther G, Islam Z, Johnston J.C, Kalyatanda G, Khosa C, Marais S, Makanda G, Mashedi OM, Meghji J, Mitnick C, Mulder C . et al. Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilizing advocacy and research for improved outcomes . IJTLD OPEN, March 1, 2024, pp. 111-123(13)
Houben RMGJ, McCaffrey T, Tiemersma EW , Khan PY. Estimating TB survival-mind the immortal-time gap . Int J Tuberc Lung Dis. 2024.
Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R et al. Modeling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa .Vaccine. 2024.
Bada FO, Blok N , Okpokoro E, Dutt S, Akolo C, Dakum P et al. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria . PLoS One. 2020.
Assefa DG , Dememew ZG, Zeleke ED, Manyazewal T, Bedru A . Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis . BMC Public Health. 2024.
Eneogu RA, Mitchell EMH, Ogbudebe C , Aboki D, Anyebe V, van der Grinten E et al. Iterative evaluation of mobile computer-assisted digital chest x-ray screening for TB improves efficiency, yield, and outcomes in Nigeria . PLOS Glob Public Health. 2024.
Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R et al. Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa. Vaccine. February 27, 2024
De Groot LM , Shearer K, Sambani C, Kaonga E , Nyirenda R, Mulder C . Health care providers acceptance of default prescribing of TB preventive treatment for people living with HIV in Malawi: a qualitative study . BMC Health Serv Res. Jan 4, 2024.
Clark RA, Sumner T, Weerasuriya CK, Bakker R , Scriba TJ, White RG. Estimating the Potential Public Health Value of BCG Revaccination . J Infect Dis. 2024.
Mitchell E, Adejumo OA, Abdur-Razzaq H, Ogbudebe C, Gidado M . The role of trust as a driver of private provider participation in disease surveillance: Cross-sectional survey from Nigeria . JMIR Public Health Surveillance. 2024.
Stuck L, Klinkenberg E, Abdelgadir Ali N, Basheir Abukaraig EA, Adusi-Poku Y, Tiemersma E et al. Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis Lancet Infect Dis. 2024.
Tadesse AW, Mganga A , Dube TN, Alacapa J, van Kalmthout K, Jerene D et al. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants – A multicountry study . Public Health Front. 2024.
Sturm PDJ, Hermans NTH , van der Zanden AGM, Peters CJA, Schülin T. Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations . Clin Microbiol Infect. 2024.